Objective
To maintain and expand the Programme EVA Centralised Facility for high quality, state-of-the-art AIDS research reagents.
To support through the provision of reagents key areas of AIDS vaccine research such as evaluation of attenuated SIV and chimaeric SIV-HIV viruses, naked DNA vaccines and the use of recombinant viral vectors.
To support through the provision of reagents clinical trials of candidate AIDS vaccine.
Proposal Summary
Programme EVA (European Vaccine against AIDS) was launched in July 1989 with the objectives of supplying high quality research reagents to support European efforts aimed at developing safe and effective vaccines against AIDS and of promoting collaborative European research projects focused on vaccine development.
Under BIOMED2, the Programme's activities will focus on providing European scientists with high quality, carefully characterised and evaluated AIDS reagents. The Programme's Centralised Facility at NIBSC (UK) has built up a large and valuable reagent repository and carries out quality control work on commissioned and donated reagents as well as on those produced "in-house". Reagents in the repository are distributed freely to members of EU Concerted Actions involved in vaccine development as well as to individual scientists as long as appropriate justification is given. Close working links with the various AIDS-vaccine-related Concerted Actions that are being supported through the BIOMED Programme will be established and maintained and the needs of these groups given high priority.
Under BIOMED 2, Programme EVA plans to maintain and expand the EVA Centralised Facility/Reagent Programme and to support the following key areas of research through the provision of reagents:
- Attenuated and chimeric viruses for protection studies in the SIV model. - Naked DNA vaccines.
- Recombinant viral vectors.
- Characterization of HIV strains prevalent at WHO vaccine evaluation sites. - Preparation of vaccines and evaluation of reagents for use in clinical studies.
Fields of science (EuroSciVoc)
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
- natural sciences biological sciences microbiology virology
- natural sciences biological sciences genetics DNA
- medical and health sciences health sciences infectious diseases RNA viruses HIV
- medical and health sciences basic medicine pharmacology and pharmacy pharmaceutical drugs vaccines
You need to log in or register to use this function
Programme(s)
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
Topic(s)
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Call for proposal
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
Data not available
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
Funding Scheme
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
Coordinator
EN6 3QG Potters Bar
United Kingdom
The total costs incurred by this organisation to participate in the project, including direct and indirect costs. This amount is a subset of the overall project budget.